Teva Pharma Target Lowered Again Following Model Update

Discussion in 'Teva Neuroscience' started by anonymous, Sep 30, 2019 at 2:06 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    "The price target on Teva Pharma (NYSE: TEVA) has been chopped by more than 50% by Wells Fargo and several other analysts following the latest model update that includes significantly more financial exposure in the opioid lawsuits than planned for, revenues continuing to go backwards, and an increased debt load due at the turn of the year. The even greater financial squeeze ahead also continues to include a "Junk" rating"
     

  2. anonymous

    anonymous Guest

    We know. Old news. But show the link to this quote so we can see that this is the most recent information.
     
  3. anonymous

    anonymous Guest

    Hey Genius, the OP posted TODAY'S headlines and releases, but you must be right though, at least in your head with your "old news" claim

    Teva's new target and the current market cap have NEVER been this low for this long, you clearly do not understand the information
     
  4. anonymous

    anonymous Guest

    Teva will survive due to political reasons in Israel. No one will buy it, even if it drops to $1 a share and the government won't allow it to go under. Relax!
     
  5. anonymous

    anonymous Guest

    Old news jerkoff
     
  6. anonymous

    anonymous Guest

    Look at this idiot, another clueless contract teva rep or maybe even a contract teva marketing intern...,errr I mean associate
     
  7. anonymous

    anonymous Guest

    Teva price target lowered to $8 from $17 at Wells Fargo TEVA - The Fly

    Since you're too lazy to do what was asked as far as showing proof of your statement, I did it for you. Wells Fargo is claiming Teva should be priced at $8 a share which is up from today's price of $6.92 So actually, your news is good news and thank you for sharing. But regarding the old news, back in July, Chase Bank said Teva should go as low as $6. So you see, you idiotic troll, Teva reps in the know, know of the old news and we know that things can be better. But again, thanks for sharing the potentially higher outlook and enjoy selling that Ingrezza crap.